Ameya Puranik

9PUBLICATIONS
31CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Animal behaviourRadiation therapyNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 01, 2026
SMARCA4-deficient Anaplastic Thyroid Carcinoma: A Hitherto Unreported Case.

|Oct 29, 2025
PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Ameya D Puranik, Indraja D Dev, Sushil Yadav

|Feb 17, 2025
Frontiers in radiopharmaceuticals for neuroendocrine tumors.

Ameya D Puranik, Indraja D Dev, Vikas Prasad

|Nov 11, 2024
FET PET to differentiate between post-treatment changes and recurrence in high-grade gliomas: a single center multidisciplinary clinic controlled study.

Ameya D Puranik, Indraja D Dev, Venkatesh Rangarajan

|Apr 28, 2023
Imaging-Based Patterns of Failure following Re-Irradiation for Recurrent/Progressive High-Grade Glioma.

Debanjali Datta, Archya Dasgupta, Abhishek Chatterjee

|Jan 27, 2023
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.

Vijay Maruti Patil, Vanita Noronha, Nandini Menon

Pageof 2

Frequent Collaborators

3 joint publications

Vinita Noronha

3 joint publications

Kumar Prabhash

2 joint publications

Mitali Alone

2 joint publications

Neha Mittal